Xu-Bao Liu

466 total citations
30 papers, 297 citations indexed

About

Xu-Bao Liu is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Xu-Bao Liu has authored 30 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 20 papers in Epidemiology and 13 papers in Neurology. Recurrent topics in Xu-Bao Liu's work include Neuroendocrine Tumor Research Advances (20 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Lung Cancer Research Studies (14 papers). Xu-Bao Liu is often cited by papers focused on Neuroendocrine Tumor Research Advances (20 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Lung Cancer Research Studies (14 papers). Xu-Bao Liu collaborates with scholars based in China, United States and Germany. Xu-Bao Liu's co-authors include Nengwen Ke, Chunlu Tan, Min Yang, Yi Zhang, Bole Tian, Yonghua Chen, Bo Xiang, Gang Mai, Bole Tian and Zhaoda Zhang and has published in prestigious journals such as Medicine, World Journal of Gastroenterology and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Xu-Bao Liu

28 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu-Bao Liu China 11 256 215 113 67 20 30 297
Yoshihide Nanno Japan 9 192 0.8× 134 0.6× 58 0.5× 100 1.5× 44 2.2× 47 256
Federica de Cicco Italy 10 169 0.7× 128 0.6× 70 0.6× 29 0.4× 18 0.9× 10 256
Sophie Dominguez France 7 154 0.6× 173 0.8× 86 0.8× 38 0.6× 32 1.6× 14 290
Kimberly Kamp Netherlands 12 322 1.3× 391 1.8× 301 2.7× 51 0.8× 13 0.7× 14 449
Yuichi Tachibana Japan 8 106 0.4× 102 0.5× 34 0.3× 56 0.8× 22 1.1× 29 190
Chunhui Yuan China 8 213 0.8× 81 0.4× 22 0.2× 83 1.2× 63 3.1× 23 262
Clifford Cho United States 7 179 0.7× 74 0.3× 33 0.3× 101 1.5× 86 4.3× 14 219
Andrew Ddembe Kiberu Australia 5 147 0.6× 62 0.3× 43 0.4× 48 0.7× 20 1.0× 7 166
Jennifer Arena Australia 8 173 0.7× 64 0.3× 21 0.2× 61 0.9× 59 3.0× 15 194

Countries citing papers authored by Xu-Bao Liu

Since Specialization
Citations

This map shows the geographic impact of Xu-Bao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu-Bao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu-Bao Liu more than expected).

Fields of papers citing papers by Xu-Bao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu-Bao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu-Bao Liu. The network helps show where Xu-Bao Liu may publish in the future.

Co-authorship network of co-authors of Xu-Bao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xu-Bao Liu. A scholar is included among the top collaborators of Xu-Bao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu-Bao Liu. Xu-Bao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ziyao, Jiajun Qiu, Fan Yang, et al.. (2025). A nomogram to preoperatively predict the aggressiveness of pancreatic neuroendocrine tumors based on CT features and 3D CT radiomic features. Abdominal Radiology. 50(8). 3662–3673.
2.
3.
Li, Yichen, et al.. (2023). Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcinoma cells. Anti-Cancer Drugs. 35(3). 227–236. 3 indexed citations
4.
Wang, Ziyao, et al.. (2022). The Role of Primary Tumor Resection in Patients With Pancreatic Neuroendocrine Tumors With Liver Metastases. Frontiers in Oncology. 12. 838103–838103. 8 indexed citations
5.
Wang, Xing, Jiajun Qiu, Chunlu Tan, et al.. (2022). Development and Validation of a Novel Radiomics-Based Nomogram With Machine Learning to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Frontiers in Oncology. 12. 843376–843376. 8 indexed citations
6.
Yang, Min, Nengwen Ke, Chunlu Tan, et al.. (2020). World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution. BMC Cancer. 20(1). 906–906. 21 indexed citations
7.
Wang, Xing, Yonghua Chen, Chunlu Tan, et al.. (2020). Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors. Medicine. 99(24). e20324–e20324. 10 indexed citations
8.
Yang, Min, et al.. (2020). Survivals of patients with pancreatic neuroendocrine carcinomas. Medicine. 99(3). e18736–e18736. 4 indexed citations
9.
10.
11.
Yang, Min, Nengwen Ke, Yi Zhang, et al.. (2017). Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system?. Oncotarget. 8(47). 82784–82795. 12 indexed citations
12.
Yang, Min, Chunlu Tan, Yi Zhang, et al.. (2016). Applications of a novel tumor-grading-metastasis staging system for pancreatic neuroendocrine tumors. Medicine. 95(28). e4213–e4213. 9 indexed citations
13.
Yang, Min, Yi Zhang, Weiguo Wang, et al.. (2015). TNM Staging of Pancreatic Neuroendocrine Tumors. Medicine. 94(12). e660–e660. 33 indexed citations
14.
15.
Su, Anping, Nengwen Ke, Yi Zhang, et al.. (2013). Is laparoscopic approach for pancreatic insulinomas safe? Results of a systematic review and meta-analysis. Journal of Surgical Research. 186(1). 126–134. 31 indexed citations
16.
Guo, Jia, Ping Xue, Xiaonan Yang, et al.. (2013). The effect of Chaiqin Chengqi Decoction (柴芩承气汤) on modulating serum matrix metalloproteinase 9 in patients with severe acute pancreatitis. Chinese Journal of Integrative Medicine. 19(12). 913–917. 8 indexed citations
17.
Xiang, Guangming, Chunlu Tan, Gang Mai, & Xu-Bao Liu. (2011). Efficacies of extended and standard radical pancreatoduodenectomy. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 10(5). 347–350. 1 indexed citations
18.
Guo, Jia, Ping Xue, Xiaonan Yang, et al.. (2011). Serum Matrix Metalloproteinase-9 is an Early Marker of Pancreatic Necrosis in Patients with Severe Acute Pancreatitis. Hepatogastroenterology. 59(117). 1594–8. 11 indexed citations
19.
Liu, Xu-Bao, et al.. (2008). Role of Pancreatic Stellate Cells in Pancreatic Fibrosis. 1 indexed citations
20.
Liu, Xu-Bao. (1999). The role of L-arginine in the treatment of acute edematous pancreatitis in rats. Zhonghua shiyan waike zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihide Nanno Breakdown of academic impact, for papers by Federica de Cicco Breakdown of academic impact, for papers by Sophie Dominguez Breakdown of academic impact, for papers by Kimberly Kamp Breakdown of academic impact, for papers by Yuichi Tachibana Breakdown of academic impact, for papers by Chunhui Yuan Breakdown of academic impact, for papers by Clifford Cho Breakdown of academic impact, for papers by Andrew Ddembe Kiberu Breakdown of academic impact, for papers by Jennifer Arena
Rankless by CCL
2026